Search Results
Jul 09, 2026, 10:15 ET Peritoneal Dialysis Market worth $14.16 billion by 2031 | MarketsandMarkets™
for the geriatric population, PD will be advantageous, as it can be done at home; this will improve quality of life, as such patients are able to remain independent and are less frequently admitted to the hospital. More importantly, existing evidence demonstrates that PD provides additional benefits for
More news about: MarketsandMarkets
Jul 09, 2026, 09:00 ET Popular Professional Development Platform Secures Impact Investment to Help Districts Better Support Their Educators
evidence of what actually changes in the classroom. Because the disparate systems used to coach and evaluate educators – observation notes, survey results, PD attendance records, evaluation scores – typically live in separate systems and rarely speak to each other, administrators must often make decisions about
More news about: KickUp
Jul 09, 2026, 08:38 ET Le nubia Neo 5 GT Édition spéciale fait son entrée sur le marché avec le premier et unique système de refroidissement actif double (par liquide et par air) de sa catégorie
fréquences d'images élevées et stables. L'appareil est alimenté par une batterie à deux cellules de 6 210 mAh, compatible avec la recharge rapide à 80 W (45 W PD dans l'Union européenne) et la recharge en dérivation. Il prend aussi en charge un mode Extreme à 5 % pour permettre jusqu'à 30 minutes de jeu supplémentaires.Une
More news about: ZTE Corporation
Jul 09, 2026, 08:31 ET MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
16 mg for 4 weeks, 32 mg for 4 weeks, and 64 mg for 8 weeks. The study will assess safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of DA-1726. Primary endpoints include monitoring adverse events (AEs), serious adverse events (SAEs), treatment-emergent adverse events (TEAEs), and
More news about: MetaVia Inc.
Jul 09, 2026, 08:15 ET Constructor Has the Most #1 Rankings in Gartner® Critical Capabilities for Search and Product Discovery Report
evaluated.2What the report evaluatedIn its Critical Capabilities report, Gartner defines search and product discovery (S&PD) solutions as "applications that augment digital commerce solutions to facilitate navigation, filtering, comparisons and, ultimately, selection of
More news about: Constructor
Jul 09, 2026, 05:28 ET InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation
87% (27/31) among evaluable patients. And tumor shrinkage was observed in all evaluable patients, even in the patient with best overall response of PD.Durable Responses: Among responders, the median Duration of Response (DOR) was Not Reached (NR) (95% CI: 15.2–NE), underscoring the potential
More news about: InxMed Co., Ltd
Jul 09, 2026, 04:38 ET nubia Neo 5 GT Special Edition Debuts with the First and Only Liquid and Air Dual Active Cooling System in Its Class
NeoTurbo Engine optimization, it's built to deliver high and stable frame rates. This device equips a 6,210mAh dual-cell battery, supported by 80W (45W PD for EU market) fast charging and Bypass Charging. It also supports 5% Extreme Mode, delivering up to 30 minutes of extra gaming.Immersive Gaming
More news about: ZTE Corporation
Jul 09, 2026, 04:12 ET nubia Neo 5 GT Special Edition Debuts with the First and Only Liquid and Air Dual Active Cooling System in Its Class
NeoTurbo Engine optimization, it's built to deliver high and stable frame rates. This device equips a 6,210mAh dual-cell battery, supported by 80W (45W PD for EU market) fast charging and Bypass Charging. It also supports 5% Extreme Mode, delivering up to 30 minutes of extra gaming.Immersive Gaming
More news about: ZTE Corporation
Jul 08, 2026, 12:00 ET On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations
for long-term value creation, not a mere transaction; deals often fail due to weak biology-disease links, poor biomarker strategies, or suboptimal PK/PD profiles. Crucially, MNCs now view China as a core innovation fountain, not a cost-driven market. To succeed, Chinese biotechs must provide globally
More news about: bioSeedin
Jul 08, 2026, 09:02 ET Parkinson's Foundation Expands Global Care Network with Five New Designations to Increase Access to Parkinson's Care
Network with the addition of five new centers. The expansion recognizes those centers that are providing excellent care to people with Parkinson's disease (PD) within a broad geographic region, including the first-ever designations in Missouri, New Jersey and Washington state.
More news about: Parkinson's Foundation
Jul 08, 2026, 09:00 ET Hollyland MELO P1 Fits a Full Recording Studio into One Wireless Case
enabling a total runtime of up to 40 hours before recharging is required. Integrated power management keeps your audio running smoothly, while USB-C PD fast charging of up to 60 W ensures minimal downtime.Pricing and AvailabilityThe MELO P1 is available through local distributors,
More news about: Hollyland
Jul 08, 2026, 09:00 ET Hollyland MELO P1 Hadirkan Studio Rekaman Lengkap dalam Satu Perangkat Nirkabel
baterai perlu diisi ulang kembali. Sistem manajemen daya terintegrasi menjaga kinerja perangkat tetap optimal, sementara fitur pengisian cepat USB-C PD hingga 60 watt turut meminimalkan waktu tunggu.Harga dan Ketersediaan Produk MELO P1 tersedia melalui distributor resmi di berbagai
More news about: Hollyland
Jul 08, 2026, 09:00 ET Hollyland MELO P1 bietet Platz für ein komplettes Aufnahmestudio in einem einzigen kabellosen Gehäuse
ein erneutes Aufladen erforderlich ist. Das integrierte Energiemanagement sorgt für einen reibungslosen Betrieb Ihres Audiogeräts, während die USB-C-PD-Schnellladefunktion mit bis zu 60 W für minimale Ausfallzeiten sorgt.Preise und VerfügbarkeitDas MELO P1 ist über lokale Händler,
More news about: Hollyland
Jul 08, 2026, 09:00 ET Hollyland MELO P1: Un estudio de grabación completo cabe en una funda inalámbrica
40 horas antes de necesitar recarga. La gestión de energía integrada garantiza un funcionamiento fluido del audio, mientras que la carga rápida USB-C PD de hasta 60 W minimiza las interrupciones.Precio y disponibilidad.El MELO P1 está disponible a través de distribuidores locales,
More news about: Hollyland
Jul 08, 2026, 09:00 ET Hollyland MELO P1 fait entrer tout un studio d'enregistrement dans un seul boîtier sans fil
soit nécessaire. La gestion intégrée de l'alimentation garantit un fonctionnement fluide de votre système audio, tandis que la recharge rapide USB-C PD pouvant atteindre 60 W assure un temps d'indisponibilité minimal.Prix et disponibilitéLe MELO P1 est disponible auprès des distributeurs
More news about: Hollyland
Jul 08, 2026, 09:00 ET Hollyland MELO P1 gói trọn cả một phòng thu âm trong một hộp đựng không dây
đến 40 giờ trước khi cần sạc lại. Hệ thống quản lý nguồn điện tích hợp giúp duy trì hoạt động âm thanh trơn tru, trong khi công nghệ sạc nhanh USB-C PD công suất lên đến 60 W bảo đảm thời gian ngừng hoạt động tối thiểu.Giá cả và thời gian mở bánMELO P1 được mở bán thông qua các nhà
More news about: Hollyland
Jul 08, 2026, 08:53 ET Quark® Unveils the BuubiBottle Portable Milk Warmer PRO: The Most Advanced Portable Milk Warmer Ever Made, Now at Target and Nordstrom
TSA-compliant lithium-ion battery, among the largest in its category.30W USB-C fast charging with an included braided cable, compatible with USB PD for any modern Type-C adapter.17oz / 500ml capacity with single-degree precision control in Celsius or Fahrenheit, compatible with liquid,
More news about: Quark Baby
Jul 08, 2026, 07:00 ET BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
GBM and other high-grade gliomas. The primary objective is to establish a maximum tolerated dose (MTD) and/or a recommended dose based on safety, PK/PD and preliminary efficacy. Updates to the Phase 1/2a trial are anticipated during H2 2026, with full results on the dose escalation part expected in 2027.The
More news about: BioLineRx Ltd.; Hemispherian AS
Jul 07, 2026, 05:27 ET American Parkinson Disease Association Announces New Training Course for Mental Health Practitioners
Parkinson's: Caring for someone with advanced PD can be complex. This course helps those who care for people with PD – particularly home health aides, nursing home staff, and visiting nurses – better understand the symptoms and challenges that come with advanced PD and how to best manage them as the disease
More news about: American Parkinson Disease Association, Inc.
Jul 06, 2026, 08:00 ET BenQ Debuts Creative Pro Line with PD2732U for Trusted Colors for Every Deliverable
offer pairing the PD2732U with BenQ's Ergo Arm at a discounted rate of $50 off. The PD2732U will be available for purchase on Bhphotovideo.com and BenQ.com starting July 22 and on Amazon.com and select retailer partners on September 1.To learn more about BenQ Creative Pro and PD2732U, please visit:
More news about: BenQ
Jul 02, 2026, 10:31 ET Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
Treatment: Front-line NSCLC represents a large market, currently only being dominated by anti-PD1 drugs and anti-PD-1 + CTx combination, leaving a significant opportunity for therapy beyond anti-PD1 to deliver higher clinical benefit. Robust NSCLC Clinical Trial Activities: The NSCLC
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 00:12 ET Fosun International Garners Five Awards from Corporate Governance Asia
and pipeline innovative drugs have delivered several "world's first" breakthroughs. HANSIZHUANG became the world's first monoclonal antibody targeting PD-1 approved for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), and has been approved for marketing in over 40 countries and
More news about: Fosun
Jul 01, 2026, 21:00 ET Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
such as PD-1 and its ligand PD-L1 to evade immune detection and clearance, thereby suppressing or limiting T-cell responses. Lumipodlin selectively binds to the PD-L1 receptor and induces its internalization from the cell surface, effectively inhibiting the PD-1/PD-L1 interaction and alleviating PD-L1-mediated
More news about: Abbisko
Jul 01, 2026, 10:46 ET Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight
xenograft, syngeneic, patient-derived xenograft (PDX), and genetically engineered mouse models (GEMMs), as well as pharmacokinetic/pharmacodynamic (PK/PD), biomarker, toxicology, and mechanism-of-action studies. By leveraging validated tumor models and advanced imaging and analytical capabilities, oncology-based
More news about: DelveInsight Business Research, LLP
Jun 30, 2026, 09:42 ET LG Electronics celebra 10 anos de P&D de software automotivo no Vietnã.
multimedia:https://www.prnewswire.com/br/comunicados-para-a-imprensa/lg-electronics-celebra-10-anos-de-pd-de-software-automotivo-no-vietna-302814610.htmlFONTE
More news about: LG Electronics Brasil